Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family

J Gastrointestin Liver Dis. 2015 Dec;24(4):523-6. doi: 10.15403/jgld.2014.1121.244.ugt.

Abstract

Background: Crigler-Najjar syndrome type I (CN-1) and type II (CN-2) are rare hereditary unconjugated hyperbilirubinemia disorders. However, there have been no reports regarding the co-existence of CN-1 and CN-2 in one family. We experienced a case of an Iranian family that included members with either CN-1 or CN-2. Genetic analysis revealed a mutation in the bilirubin UDP-glucuronosyltransferase (UGT1A1) gene that resulted in residual enzymatic activity.

Case report: The female proband developed severe hyperbilirubinemia [total serum bilirubin concentration (TB) = 34.8 mg/dL] with bilirubin encephalopathy (kernicterus) and died after liver transplantation. Her family history included a cousin with kernicterus (TB = 30.0 mg/dL) diagnosed as CN-1. Her great grandfather (TB unknown) and uncle (TB = 23.0 mg/dL) developed jaundice, but without any treatment, they remained healthy as CN-2.

Results: The affected cousin was homozygous for a novel frameshift mutation (c.381insGG, p.C127WfsX23). The affected uncle was compound heterozygous for p.C127WfsX23 and p.V225G linked with A(TA)7TAA. p.V225G-UGT1A1 reduced glucuronidation activity to 60% of wild-type. Thus, linkage of A(TA)7TAA and p.V225G might reduce UGT1A1 activity to 18%-36 % of the wild-type.

Conclusion: Genetic and in vitro expression analyses are useful for accurate genetic counseling for a family with a history of both CN-1 and CN-2.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bilirubin / blood
  • Biomarkers / blood
  • COS Cells
  • Child, Preschool
  • Chlorocebus aethiops
  • Crigler-Najjar Syndrome / diagnosis
  • Crigler-Najjar Syndrome / enzymology
  • Crigler-Najjar Syndrome / genetics*
  • Crigler-Najjar Syndrome / therapy
  • DNA Mutational Analysis
  • Fatal Outcome
  • Female
  • Genetic Predisposition to Disease
  • Glucuronosyltransferase / genetics*
  • Glucuronosyltransferase / metabolism
  • Heredity
  • Humans
  • Infant, Newborn
  • Iran
  • Liver Transplantation
  • Male
  • Mutation*
  • Phenotype
  • Transfection
  • Treatment Outcome

Substances

  • Biomarkers
  • UGT1A1 enzyme
  • Glucuronosyltransferase
  • Bilirubin

Supplementary concepts

  • Crigler Najjar syndrome, type 2

Associated data

  • GENBANK/LC005519